Zephyrm
Latest round
- Series B
Last raised
- Apr 2023
Total raised
- $29M
Investors
- 7
About Zephyrm
Established in 2018 and based in Beijing, China, Zephyrm is a biotech company that focuses on stem cell drug development and production. In May 2019, it established a GMP stem cell drug production plant in Zhongguancun Science and Technology Park in Beijing, and the stem cell drug production plant is equipped with complete cell culture and testing facilities. In September 2021, it received approval for a new drug clinical trial for stem cell drugs to treat meniscal injuries. The company's main business is stem cell drug development and production. Its stem cell drug products are mainly involved in meniscal injuries in the osteoarticular system, acute respiratory distress syndrome and pulmonary fibrosis-related diseases in the respiratory system, and early-onset ovarian insufficiency in the reproductive system.
Who invested in Zephyrm
7 investors across 3 rounds
See all investors in Zephyrm
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zephyrm
Who invested in Zephyrm?
Zephyrm has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zephyrm raised?
Zephyrm has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Zephyrm last raise money?
Zephyrm's most recent round on record is a Series B, in Apr 2023.
What does Zephyrm do?
Established in 2018 and based in Beijing, China, Zephyrm is a biotech company that focuses on stem cell drug development and production.
Where is Zephyrm headquartered?
Zephyrm is headquartered in Beijing, China.
Which VCs invest in companies like Zephyrm?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Zephyrm's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Zephyrm? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.